China A-share innovative drug sector weakened sharply: Yuheng Pharmaceutical, Hansen Pharmaceutical and Jiankai Technology hit daily limit-down; Transcenta Life Sciences and Wanbang Medicine fell more than 10%; Zhongguancun, Xidian Pharmaceutical, Qianjin Pharmaceutical, Puris and Longshen Rongfa also slid.

2026-08-31

China A-share innovative drug sector weakened sharply: Yuheng Pharmaceutical, Hansen Pharmaceutical and Jiankai Technology hit daily limit-down; Transcenta Life Sciences and Wanbang Medicine fell more than 10%; Zhongguancun, Xidian Pharmaceutical, Qianjin Pharmaceutical, Puris and Longshen Rongfa also slid.